- A for-profit company that Peter Thiel invests in has plans to start clinical trials of magic mushrooms for depression within the first three months of 2018.
- Psychedelics appear to disrupt the brain's activity patterns in a positive and life-changing way.
- Several research institutions are studying psychedelics for their potential to treat depression, anxiety, addiction, and PTSD.
Wednesday, December 13, 2017
Psilocybin for Depression
Peter Thiel is betting on magic mushrooms to treat depression — and he's not the only one
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment